Transformation Capital focuses exclusively on growth-stage digital health, healthcare IT, and tech-enabled services that simplify complexity, lower costs, and improve patient care.
About Transform Capital
Transform Capital, formerly known as Transformation Capital, is a healthcare-focused growth equity firm specializing in late-stage digital health and healthcare technology investments. The firm operates with a sector-specialist mandate and has built a reputation for backing companies in clinical software, virtual care, healthcare data infrastructure, and adjacent technology categories at significant scale. Check sizes are large by venture standards, typically beginning at twenty million dollars and scaling well into nine figures for larger transactions, with the firm able to lead growth rounds and act as a primary partner through to exit. The natural fit is a healthcare technology company with material revenue, a defined buyer, defensible economics, and ambitions for either organic acceleration or strategic M&A. Healthcare AI founders can engage at growth stage if there is meaningful enterprise traction, strong unit economics, and a credible plan for capital deployment. Pre-revenue companies, seed-stage software businesses, and biopharma research-stage assets are out of scope and should look to early-stage investors. Founders should expect rigorous, healthcare-fluent diligence with input from clinical, payer, and operational advisors, careful commercial analysis, and active engagement on operations and management team build-out post-investment. The best entry path is via a healthcare-focused growth equity banker, a strategic advisor with Transform relationships, or a warm introduction from a portfolio CEO. Direct outreach to partners on LinkedIn is also a credible path when the company is at clear growth-stage scale, with metrics and round dynamics that justify a sector-specialist late-stage lead.
Founder reviews
Healthcare AI tools backed by Transform Capital
Tools made by companies in Transform Capital's portfolio that we cover in the directory.
Portfolio companies in our directory
Other portfolio companies
Companies in Transform Capital's portfolio not currently in our directory.
- Latent · 2026
- Ketryx Corporation · 2025
- Solstice · 2026
- Alaffia Health · 2026
- Groups Recover Together · 2019
- Nayya · 2022
Team
Pitch / review this investor
Have you raised from Transform Capital? Founders only — share your honest experience (anonymous OK, moderated before publishing).